awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q39057046-3894319E-F17C-46C9-883A-F5E2FB0E244C
Q39057046-3894319E-F17C-46C9-883A-F5E2FB0E244C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39057046-3894319E-F17C-46C9-883A-F5E2FB0E244C
PCSK9 inhibition: the dawn of a new age in cholesterol lowering?
P2860
Q39057046-3894319E-F17C-46C9-883A-F5E2FB0E244C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39057046-3894319E-F17C-46C9-883A-F5E2FB0E244C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
242bc4685d1eff6a2f82026cc6c5756024c5350d
P2860
No effect of PCSK9 inhibitor alirocumab on the incidence of diabetes in a pooled analysis from 10 ODYSSEY Phase 3 studies.